Finding a receptor interaction identifies a possible biological mechanism. It does not determine whether activating that mechanism is beneficial in every tissue, disease or clinical setting.
A primary study of hexarelin and CD36 used animal cardiac membranes and perfused hearts to investigate a molecular target. It reported a coronary-perfusion-pressure response that depended on CD36 in the studied models. That is not a human trial of cardiovascular prevention or treatment.
Mechanistic language can conceal the direction of an effect
Words such as “cardiac activity” or “receptor binding” are neutral until the measured response is explained. They should not automatically become “cardioprotection.” A pathway can have different consequences depending on the model and biological circumstances.
The experiment is valuable because it asks how an effect may occur and uses model comparisons to investigate that question. Its strength is mechanistic specificity, not proof of a general patient benefit.
To read such a paper responsibly, separate the model, intervention and outcome. An isolated-heart response is not a clinical symptom. A genetically altered animal comparison is not a population safety study. The more clearly these levels are stated, the less likely a reader is to mistake laboratory causation for a treatment recommendation.
The finding also cannot identify what is inside an unrelated research vial. A compound literature citation and a product-quality assessment answer different questions.
This article is an editorial extension, not a question claimed to be frequent in the sampled Reddit discussions. It was included because broad heart-protection claims can otherwise borrow authority from receptor research without preserving the actual result.
The conclusion should remain narrow: CD36-related cardiovascular activity was investigated in experimental models. Whether a particular intervention helps or harms people with a specific condition requires appropriate human evidence. Nothing in this summary supports replacing cardiac care or using a research peptide for self-directed prevention.